Paper16458302
The muO-conotoxin MrVIA inhibits voltage-gated sodium channels by associating with domain-3.
Zorn S and 6 others. FEBS Lett, 2006. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. The muO-conotoxin MrVIA inhibits voltage-gated sodium channels by associating with domain-3. Papers, record 16458302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16458302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Conotoxins | Major topic |
| Sodium Channel Blockers | Major topic |
| Sodium Channels | Major topic |
| Animals | |
| Binding Sites | |
| Brain Chemistry | |
| Cloning, Molecular | |
| Conus Snail | |
| Muscle Proteins | |
| Muscle, Skeletal | |
| NAV1.2 Voltage-Gated Sodium Channel | |
| Nerve Tissue Proteins | |
| Rats |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM48677 | NIGMS NIH HHS | United States | P01GM048677 | PubMed and NIH |
Source NIH RePORTER
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38914468 | Conotoxins Targeting Voltage-Gated Sodium Ion Channels. | Pharmacol Rev | 2024 | https://conductscience.org/library/papers/38914468 | PubMed |
| 37103349 | Historical Perspective of the Characterization of Conotoxins Targeting Voltage-Gated Sodium Channels. | Mar Drugs | 2023 | https://conductscience.org/library/papers/37103349 | PubMed |
| 36038266 | Extracellular hemin is a reverse use-dependent gating modifier of cardiac voltage-gated Na+ channels. | Biol Chem | 2022 | https://conductscience.org/library/papers/36038266 | PubMed |
| 34677461 | Voltage-Gated Sodium Channels: A Prominent Target of Marine Toxins. | Mar Drugs | 2021 | https://conductscience.org/library/papers/34677461 | PubMed |
| 31234371 | Structural and Functional Analyses of Cone Snail Toxins. | Mar Drugs | 2019 | https://conductscience.org/library/papers/31234371 | PubMed |
| 30863305 | Venom-Derived Peptide Modulators of Cation-Selective Channels: Friend, Foe or Frenemy. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/30863305 | PubMed |
| 28937587 | µ-Conotoxins Modulating Sodium Currents in Pain Perception and Transmission: A Therapeutic Potential. | Mar Drugs | 2017 | https://conductscience.org/library/papers/28937587 | PubMed |
| 28749537 | Sodium channels and pain: from toxins to therapies. | Br J Pharmacol | 2018 | https://conductscience.org/library/papers/28749537 | PubMed |
| 27026701 | Development of a μO-Conotoxin Analogue with Improved Lipid Membrane Interactions and Potency for the Analgesic Sodium Channel NaV1.8. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27026701 | PubMed |
| 26712848 | The hitchhiker's guide to the voltage-gated sodium channel galaxy. | J Gen Physiol | 2016 | https://conductscience.org/library/papers/26712848 | PubMed |
| 26690478 | Conotoxins That Could Provide Analgesia through Voltage Gated Sodium Channel Inhibition. | Toxins (Basel) | 2015 | https://conductscience.org/library/papers/26690478 | PubMed |
| 24737238 | Animal toxins influence voltage-gated sodium channel function. | Handb Exp Pharmacol | 2014 | https://conductscience.org/library/papers/24737238 | PubMed |
| 23202314 | Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics? | Toxins (Basel) | 2012 | https://conductscience.org/library/papers/23202314 | PubMed |
| 22452751 | Biophysical properties of Na(v) 1.8/Na(v) 1.2 chimeras and inhibition by µO-conotoxin MrVIB. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/22452751 | PubMed |
| 22007172 | Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes. | Front Pharmacol | 2011 | https://conductscience.org/library/papers/22007172 | PubMed |
| 21586605 | Navβ subunits modulate the inhibition of Nav1.8 by the analgesic gating modifier μO-conotoxin MrVIB. | J Pharmacol Exp Ther | 2011 | https://conductscience.org/library/papers/21586605 | PubMed |
| 21147978 | A diverse family of novel peptide toxins from an unusual cone snail, Conus californicus. | J Exp Biol | 2011 | https://conductscience.org/library/papers/21147978 | PubMed |
| 18486102 | Specificity, affinity and efficacy of iota-conotoxin RXIA, an agonist of voltage-gated sodium channels Na(V)1.2, 1.6 and 1.7. | Biochem Pharmacol | 2008 | https://conductscience.org/library/papers/18486102 | PubMed |
| 17077153 | muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/17077153 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16458302
GET https://conductscience.org/api/papers/v1/16458302/authors